<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00437580</url>
  </required_header>
  <id_info>
    <org_study_id>CHU63-0015</org_study_id>
    <nct_id>NCT00437580</nct_id>
  </id_info>
  <brief_title>Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage</brief_title>
  <official_title>Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus (VRE) Intestinal Carriage : a Double Blind Randomized Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      This study aims to reduce the duration of VRE intestinal carriage by the administration of
      Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be
      assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks
      regimen with placebo.A stool culture will be performed every week for 5 weeks (during the
      administration of treatment) then every two weeks until 3 consecutive negative stool culture
      for VRE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to reduce the duration of VRE intestinal carriage by the administration of
      Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be
      assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks
      regimen with placebo.A stool culture will be performed every week for 5 weeks (during the
      administration of treatment) then every two weeks until 3 consecutive negative stool culture
      for VRE.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2007</start_date>
  <completion_date type="Anticipated">August 2009</completion_date>
  <primary_completion_date type="Anticipated">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of the duration of Vancomycin Resistant Enterococcus intestinal carriage.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Vancomycin Resistant Enterococcus Intestinal Carriage</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactobacillus casei rhamnosus (strain Lcr 35 LC)</intervention_name>
    <description>Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic or to a 5 weeks regimen with placebo.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18;

          -  Vancomycin Resistant Enterococcus intestinal carriage

        Exclusion Criteria:

          -  Neutropenia &lt;1000 /mm3,

          -  Immunosuppressive drugs,

          -  Inhalation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier LESENS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier LESENS</last_name>
    <email>olesens@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service des Maladies infectieuses et tropicales</name>
      <address>
        <city>HÃ´pital Gabriel Montpied</city>
        <state>Clermont-Ferrand</state>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2007</study_first_submitted>
  <study_first_submitted_qc>February 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2007</study_first_posted>
  <last_update_submitted>January 18, 2011</last_update_submitted>
  <last_update_submitted_qc>January 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2011</last_update_posted>
  <responsible_party>
    <name_title>Olivier LESENS</name_title>
    <organization>CHU Clermont-Ferrand</organization>
  </responsible_party>
  <keyword>Vancomycin Resistant Enterococcus, probiotic</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

